Clinical Trials Logo
  1. Home
  2. Pulmonary Tuberculosis
  3. NCT00803322
  4. Details
NCT00803322 Clinical Trial

Improving Community Based Tuberculosis Care in Ethiopia

Pulmonary Tuberculosis Clinical Trial

— community  

Official title:
Community Health Workers Improve Tuberculosis Case Notification and Treatment Success in Southern Ethiopia

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00803322
Other study ID # 0001
Secondary ID 001
Status Completed
Phase Phase 4
First received December 3, 2008
Last updated December 4, 2008
Start date September 2006
Est. completion date April 2008

Study information
Verified date December 2008
Source University of Bergen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to see if involving community health workers improves tuberculosis case finding and treatment outcome.

Description:

Tuberculosis suspects in the study area

Outcome smear positive tuberculosis cases identified smear positive tuberculosis cases treated

Recruitment information / eligibility
Status Completed
Enrollment 318
Est. completion date April 2008
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- suspects of pulmonary tuberculosis

Exclusion Criteria:

- not in the study area

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Ethiopia Dale and Wonsho districts Sidama zone, Southern Ethiopia Yirgalem Snnpr

Sponsors (2)
Lead Sponsor Collaborator
University of Bergen Centre for International Health, SNNP Regional health Bureau

Country where clinical trial is conducted

Ethiopia, 

Outcome
Type Measure Description Time frame Safety issue
Primary smear positive tuberculosis case notification rate september 2006 - setmeber 2007
Secondary smear positive treatment success rate september 2006 - April 2007
See also
  Status Clinical Trial Phase
Completed NCT02736864 - Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae N/A
Not yet recruiting NCT04055441 - A Study of Pattern of Presentation of Pulmonary Tuberculosis Patients Undergoing Treatment at Assiut University Hospital
Completed NCT02349841 - Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis Phase 2
Completed NCT01927159 - Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers Phase 1
Active, not recruiting NCT01691534 - Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z) Phase 2
Completed NCT00834353 - Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis N/A
Withdrawn NCT03277742 - Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz N/A
Completed NCT00057434 - Vitamin A Therapy for Tuberculosis Phase 3
Not yet recruiting NCT06192160 - Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis Phase 2
Recruiting NCT06127641 - Rehabilitation of People With Post-tuberculosis Lung Disease N/A
Recruiting NCT06058299 - Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis Phase 2
Completed NCT04550832 - PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) Phase 2
Completed NCT02912832 - Prospective Assessment of TBDx Feasibility N/A
Completed NCT01215851 - Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) Phase 2
Recruiting NCT01503099 - Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease N/A
Completed NCT04608955 - Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 Phase 2
Recruiting NCT05046366 - Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology.
Completed NCT05896930 - Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis Phase 2
Completed NCT02279875 - A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) Phase 2
Completed NCT02554318 - Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia N/A